(Q85630736)

English

Cancer therapy based on a mechanism of action for controlling the immune system and the resulting patent portfolio

scientific article published on 01 January 2013

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 February 2020

title

Cancer therapy based on a mechanism of action for controlling the immune system and the resulting patent portfolio (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 February 2020

author name string

Visala C Goswitz

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 February 2020

Z Peter Sawicki

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 February 2020

publication date

1 January 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 February 2020

published in

Recent patents on endocrine, metabolic & immune drug discovery

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 February 2020

volume

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 February 2020

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 February 2020

page(s)

1-10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 February 2020

Identifiers

DOI

10.2174/187221413804660926

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215852%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 February 2020

PubMed publication ID

23215852

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215852

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215852%20AND%20SRC:MED&resulttype=core&format=json

(Q85630736)

Cancer therapy based on a mechanism of action for controlling the immune system and the resulting patent portfolio

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)